Treatment of ascites: Old and new remedies

Digestive Diseases

Volumn 14, Issue 3, 1996, Pages 145-156

  Inturri, Paolo ^a,b   Graziotto, Aguese ^a,b   Rossaro, Lorenzo ^a,b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Ascites; Diuretics; Liver transplantation; Paracentesis; Reinfusion of concentrated ascites; Transjugular intrahepatic portosystemic shunt

Indexed keywords

DIURETIC AGENT;

ASCITES; CHRONIC DISEASE; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; PARACENTESIS; PERITONEUM VEIN SHUNT; PORTOSYSTEMIC ANASTOMOSIS; REVIEW;

ASCITES; CHRONIC DISEASE; DIURETICS; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; PARACENTESIS; PERITONEOVENOUS SHUNT; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC;

EID: 0030132998     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000171546     Document Type: Article

References (75)

1. Runyon BA: Care of patients with ascites. N Engl J Med 1994:330: 337-342.
2. D'amico G, Morabilo A, Pagliaro L, Marubini E: Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig DisSci 1986:31:468-475.
3. Powell WJ Jr., Klaskin G: Duration of survival in patients with Laen-nec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med 1968;44:406-420.
4. Fogel MR, Sawheny VK, Neal EA, Miller RG, Knauer CM, Gregory PB: Diuresis in the ascitic patients: A randomized controlled trial of three regimens. J Clin Gastroenterol 1981:3(suppl 1):73-80.
5. Eaffi G, Ea Villa G, Pinzani M, Carloni V, Casini Raggi V, Gentilini P: Refractory ascites: Definition, pathogenesis and treatment. Ann ltal Med Int 1993:8:38-46.
6. Epstein M: Renal sodium handling in liver disease: in Epstein M (ed): The Kidney in Liver Disease, ed 3. Baltimore, Williams & Wilkins, 1988, pp 3-30.
7. Longmire-Cook SJ: Pathophysiologic factors and management of ascites. Surg Gynecol Obstct 1993: 176:191-202.
8. Henriksen JH, Bendtsen F, Sorensen TIA, Slodeager C, Ring-Larsen H: Reduced central blood volume in cirrhosis. Gastroenterology 1989: 97:1506-1513.
9. Bernardi M, Santini C, Trevisani F: Renal function impairment induced by change in posture in patients with cirrhosis and ascites. Gut 1985:26: 629-635.
10. Ring-Larsen H, Henriksen JH, Wilken C, Clausen J, Pals H, Christensen NJ: Diuretic treatment in decompensated cirrhosis and congestive heart failure: Effects of posture. Br Med J 1986:292:1351-1353.
11. Kamard DR, Tembulkar P, Abraham P, Desai NK: Head-down lilt as a physiological diuretic in normal controls and in patients with fluid-retaining stales. Lancet 1987;ii:525-528.
12. Arroyo V, Rodes J: A rational approach to the treatment of ascites. Postgrad Med J 1975:51:558-562.
13. Gerbes AL: Medical treatment of ascites in cirrhosis. J Hepatol 1993: 17(suppl 2):S4-S9.
14. Gregory PB, Brockelschen IH, Hill MD, Lipton AB, Knaucr CM, Egger M, Miller R: Complications of diuresis in the alcoholic patient with ascites: A controlled trial. Gastroenterology 1977;73:534-538.
15. Pockros PJ, Reynolds TB: Rapid diuresis in patients with ascites from chronic liver disease: The importance of peripheral edema. Gastroenterology 1986;90:1827-1833.
16. Shear L, Ching S, Gabuzda GJ: Compartmentalization of ascites and edema in patients with hepatic cirrhosis. N Engl J Med 1970;282: 1391-1396.
17. Sherlock S, Senewiratne B, Scott A, Walker JG: Complications of diuretic therapy in hepatic cirrhosis. Lancet 1966;i: 1049-1053.
18. Fuller RK, Khambatta PB, Gobezie GC: An optimal diuretic regimen for cirrhotic ascites: A controlled trial evaluating safety and efficacy of spironolactone and furosemide. JAMA 1977:237:972-975.
19. Perez Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, Rivera F, Rodés J: Randomized comparative study of efficacy of furosemide versus spironolactone in nonazo-temic cirrhosis with ascites: Relationship between the diuretic response and the activity of the rcnin-aldosterone system. Gastroenterology 1983;84:961-968.
20. Boyer TD, Warnock DG: Use of diuretics in the treatment of cirrhotic ascites. Part 1. Gastroenterology 1983:84:1051-1055.
21. Epstein M: Diuretic therapy in liver disease; in Epstein M (ed): The Kidney in Liver Disease, ed 3. Baltimore, Williams & Wilkins. 1988. pp 537-550.
22. Arroyo V, Ginés P, Planas R: Treatment of ascites in cirrhosis. Gastroenterol Clin N Am 1992;21:237-256.
23. Sungaila I, Barile WR, Walker SE, DeAngelis C, Uelrechl J, Pappas C, Vidins E: Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites. Gastroenterology 1992; 102:1680-1685.
24. Campra JL, Reynolds TB: Effectiveness of high-dose spironolactone therapy in patients with chronic liver disease and relatively refractory ascites. Am J Dig Dis 1978:23: 1025-1030.
25. Ostcr JR, Perez GO: Acid-base homeostasis and pathophysiology in liver disease: in Epstein M (ed): The Kidney in Liver Disease, cd 3. Baltimore. Williams & Wilkins, 1988, pp 119-131.
26. Pinzani M, Daskalopoulos G, Laffi G, Gentilini P, Zipser RD: Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance. Gastroenterology 1987:92: 294-298.
27. Arroyo V, Gines P, Planas R, Panes J, Rodés J: Paracentesis in the management of cirrhotic with ascites; in Epstein M (ed): The Kidney in Liver Disease, ed 3. Baltimore. Williams & Wilkins, 1988, pp 578-592.
28. Epstein M, Lepp BA, Hollman DS, et al: Potentiation of furosemide by metolazone in refractory edema. CurrTher Res 1977;21:656-667.
29. Gerbes AL, Bertheau-Reith U, Falkner C, Jungst D, Paumgartner G: Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double-blind cross-over trial. J Hepatol 1993; 17: 353-358.
30. Laffi G, Marra F, Buzzelli G, Az-zena G, Meacci E, De Feo ML, La Villa G, Gentilini P: Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: A randomized, double-blind study. Hepatology 1991;13:1101-1105.
31. Gerbes AL, Arendt RM, Genzer R, Schnizer W, Jungst D, Paumgartner G, Wemze H: Role of atrial natriuretic factor, cyclic GMP and the rcnin-aldoslerone system in acute volume regulation of healthy human subjects. Eur J Clin Invest 1988; 18: 425-429.
32. Schricr RW, Arroyo V, Bernardi M, Epstein M, Henricksen JH, Rodes J: Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-1157.
33. Lenz K, Hortnagl H, Druml W, Reiter H, Schmid R, Schneeweiss B, Laggner A, Grimm G, Gerbes AL: Orniprcssin in the treatment of functional renal failure in decompensated liver cirrhosis: Effects on renal hemodynamics and atrial natriuretic factor. Gastroenterology 1991;101:1060-1067.
34. Ascione A, Burroughs AK: Paracentesis for ascites in cirrhotic patients. Gastroenterol Int 1990;3:120-123.
35. Quintero E, Gines P, Arroyo V, Ri-mola A, Bory F, Planas R, Viver J, Cabrera J, Rodes J: Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites: Preliminary results of a randomized controlled trial. Lancet 1985;i:611-612.
36. Gines P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Riniola A, Viver J, Camps J, Jimenez W, Mastai R, Gaya J, Rodes J: Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites: Results of a randomized study. Gastroenterology 1987:93:234-241.
37. Tito LI, Gines P, Arroyo V, Planas R, Panes J, Rimola A, Llach J, Humbert P, Badalamenti S, Jimenez W, Rodes J: Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. Gastroenterology 1990;98:146-151.
38. Gines P, Arroyo V: Paracentesis in the management of cirrhotic ascites. J Hepatol 1993:17(suppl 2):S14-S18.
39. Rubinstein D, MeLennes I, Dudley F: Morbidity and mortality after peri-toneovenous shunt surgery for refractory ascites. Gut 1985:26:1070-1073.
40. Kao HW, Rakov NE, Savage E, Reynolds TB: The effect of large-volume paracentesis on plasma volume: A cause of hypovolemia? Hepatology 1985;5:403-407.
41. Pinto PC, Amerian I, Reynolds TB: Large-volume paracentesis in non-ocdematous patients with tense ascites: Its effect on intravascular volume. Hepatology 1988;8:207-210.
42. Gines P, Tito LI, Arroyo V, Planas R, Panes J, Viver J, Torres M, Humbert P, Rimola A, Llach J, Badalamcnti S, Jimenez W. Gaya J. Rodes J: Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988:94: 1493-1502.
43. Panos MZ, Moore K, Vlavianos P, et al: Single, total paracentesis for tense ascites: Sequential hemodynamic changes and right atrial size. Hepatology 1990; 11:662-667.
44. Simon DM, McCain JR, Bonkovsky HL, Wells JO, Hartle DK, Galambos JT: Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function. Hepatology 1987:7: 423-429.
45. Salerno F, Badalamenti S, Lerenzano E, Moser P, Incerti P: Randomized comparative study of Hemaceel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology 1991: 13:707-713.
46. Salerno F: Large-volume paracentesis and volume re-cxpansion: Can synthetic plasma expanders safely replace albumin? J Hepatol 1992: 14:143-145.
47. Runyon BA, Antillon MR, Montano AA: Effect of diuresis versus therapeutic paracentesis on ascitic fluid opsonic activity and scrum complement. Gastroenterology 1989:97: 158-162.
48. Rossaro L, Graziotto A, Bonato S, Plebani M, Van Thiel DH, Burlina A, Naccarato R, Salvagnini M: Concentrated ascitic fluid rcinfusion after cascade filtration in tense ascites. Dig Dis Sci 1993;38:903-908.
49. Wilkinson SP, Handcrson J, Davidson AR, Williams R: Ascites rcinfusion using the Rhodiascil apparatus: Clinical experience and coagulation abnormalities. Postgrad Med J 1975:51:583-587.
50. Smart HL, Triger DR: A randomized prospective trial comparing daily paracentesis and intravenous albumin with recirculation in diuretic refractory ascites. J Hepatol 1990:10:191-197.
51. Martin A, Rossaro L, Sturniolo GC, Naccarato R: Treatment of refractory ascites by concentrated ascitic fluid reinfusion; in Okolicsànyi L. Cosmos G, Crcpaldi G (eds): Assessment and Management of Hepatobiliary Disease. Berlin, Springer, 1987. pp 303-307.
52. Wilde JT, Cooper P, Kennedy HJ, Triger DR. Preston FE: Coagulation disturbances following ascites recirculation. J Hepatol 1990:10:217-222.
53. Valbonesi M, Torre GC, Capra C, Frisoni R. Tesla R, Zia S, Ferrari M: Reverse cascade filtration of ascitic fluid: Preliminary results. IntJ Artif Organs 1988;11:134-138.
54. Bcrnardi M, Gasbarrini A, Trevisani F, Caraceni P, De Collibus C, Colantoni A, Andreone P, Cursaro C, Ligabue A, Gasbarrini G: Hemodynamic and renal effects of ascites aphcrcsis. concentration and reinfusion in advanced cirrhosis. J Hepatol 1995;22:10-16.
55. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Peramau J-M, Berger E, Blum U, Gabehmann A, Hauenstein K, Langer M, Gerok W: The transjugular intrahepatic portosystemic stent-shunt procedure for var-iceal bleeding. N Engl J Med 1994; 330:165-171.
56. Ring EJ, Lake JR, Roberts JP, Gordon RL, LaBerge JM, Read A: Percutaneous intrahepatic portosystemic shunts to control variceal bleeding prior to liver transplantation. Ann Intern Med 1992; 116: 304-309.
57. LaBerge JM, Sontberg KA, Lake JR, et al: Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: Results in 90 patients. Gastroenterology 1995;108:1143-1151.
58. Ochs A, Rossle M, Haag K, et al: The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192-1197.
59. Quiroga J, Sangro B, Nünez M, et al: Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995:21: 986-994.
60. Ferrai H, Bjamasion H, Wegryn SA, Rengel GJ, Nazarian GK, Rank JM, Tadavarthy SM, Hunter DW, Castaneda-Zuniga WR: Refractory ascites: Early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 1993; 189:795-801.
61. Somberg KA, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM: Transjugular intrahepatic portosystemic shunts for refractory ascites: Assessment of clinical and hormonal response and renal function. Hepatology 1995:21:709-716.
62. Wong F, Blendis L: Transjugular intrahepatic portosystemic shunt for refractory ascites: Tipping the sodium balance. Hepatology 1995:22: 358-364.
63. Spaltr L, Fenyves D, N’guyen V: Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 1995:90:1169-1171.
64. Lake JR, Ring E, LaBerge J, Gordon R, Roberts J, Ascher N: Transjugular intrahcpatic portacaval stent shunts in patients with renal insufficiency. Transplant Proc 1993;25: 1766-1767.
65. Ochs A, Ròssle M, Haag K, Gerbes A: TIPS for hepatorenal syndrome (abstract). Hcpatology 1994:20: 114A.
66. Franco D, Vons C, Traynor O, Srnadja C: Should portal systemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis? Arch Surg 1988:123:987-991.
67. Laffi G: Definition and pathogenetic mechanisms of refractory ascites: in Gentilini P. Arias 1M. Arroyo V, Schricr RW (eds): Liver Diseases and Renal Complications. New York, Raven Press. 1990. pp 345-355.
68. Gines P, Arroyo V, Vargas V, Planas R, Casafont F, Panes J, Hoyos M, Viladomio L, Rimola A, Morillas R, Salmeron M, Gines A, Esteban R, Rodes J: Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991:325:829-835.
69. Wapnick S, Grosberg JJ, Evans MI: Randomized prospective matched pair study comparing peritoneo-ve-nous shunt and conventional therapy in massive ascites. Br J Surg 1979:66:667-670.
70. Stanley MM, Ochi S, Lee KK, Nemehausky BA, Greenlee HB, Allen JI, Allen MJ, Baum RA, Gadacz TR, Camara DS, Caruana JA, Schiff ER, Livingstone AS, Samanta AK, Najem AZ, Glick ME, Julcr GL, Adham N, Baker JD, Cain GD, Jordan PH, Wolf DC, Fulenwider JT, James KE, The Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites: Peritoneovenous shunting as compared with medical treatment in patients w ith alcoholic cirrhosis and massive ascites. N Engl J Med 1989; 321:1632-1638.
71. Linas SL, Schaeffer JW, Moore F.F, Good JT Jr., Giansiracusa R: Peri-toneovenous shunt in the management of the hepatorenal syndrome. Kidney lnt 1986:30:736-740.
72. Starzl TE, Demetris AJ, Van Thiel DH: Liver transplantation. Parts 1, 2. N Engl J Med 1989:321:1014-1022. 1092-1099.
73. − after orthotopic liver transplantation. N Engl J Med 1973:289:1155-1159.
74. European FK506 Multicenter Study Group: Randomized trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994:344: 423-428.
75. Starzl TE: Medawar Prize Lecture. Liver alio- and xenotransplantation. Transplant Proc 1993:25:15-17.